iTeos Therapeutics Inc (ITOS) stock has gained 8.42% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With ITOS Stock Today?
iTeos Therapeutics Inc (ITOS) stock is higher by 4.73% while the S&P 500 is lower by -1.86% as of 3:34 PM on Tuesday, Oct 27. ITOS has risen $1.11 from the previous closing price of $23.49 on volume of 73,079 shares. Over the past year the S&P 500 has gained 5.11% while ITOS has risen 2242.86%. ITOS lost -$0.88 per share in the over the last 12 months.
To see the top 5 stocks in the Biotechnology industry click here.
More About iTeos Therapeutics Inc
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.
Click Here to get the full Stock Score Report on iTeos Therapeutics Inc (ITOS) Stock.
